<DOC>
	<DOCNO>NCT00546000</DOCNO>
	<brief_summary>A multi-center , open-label , Phase IV , unblinded study use Cutivate ( fluticasone propionate , 0.05 % ) lotion 's possible effect HPA axis infant diagnose atopic dermatitis .</brief_summary>
	<brief_title>Cutivate Lotion HPA Axis Pediatric Study</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Subjects 312 month age Subjects diagnose Atopic Dermatitis ( AD ) â‰¥35 % Body Surface Area Subjects meet protocol specific AD sign symptom severity score Subjects condition effect HPA Axis Subjects clinically significant systemic disease Subjects require treatment systemic topical retinoids study Subjects treat various chronic therapy identify protocol Subjects receive investigational drug treatment within 30 day prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>